:: year 8, Issue 31 (6-2016) ::
3 2016, 8(31): 20-28 Back to browse issues page
Therapeutic Effects of thiamine (vitamin B1) in the Improvement of Vascular Complications of Diabetic Patients
Nahid Einollahi 1, Fatemeh Safari1
1- School of Allied Medicine, Tehran University of Medical Sciences, Tehran, Iran
Abstract:   (18370 Views)

Introduction: Various pathogenesis and daily increase in number of diabetic patients, emphasizes the necessity of finding new therapeutic methods. Nowadays, physicians focus on controlling the blood sugar, although the protections against diabetic complications like: retinopathy, nephropathy and neuropathy are being ignored. Several studies on diabetic patients suggest that thiamine metabolism in diabetic is deficient. Thiamine(vitamin B1) is an essential cofactor of several enzymes involved in carbohydrates metabolism. Therefore, the aim of this study is to review the physiological role of thiamine in metabolism of glucose and the effectiveness of thiamine on lowering the secondary diabetes complication.

Materials and Methods: The study is done by searching the English and Persian databases like: Pubmed, Scopus, Proquest, Google scholar, SID, Magiran and Iranmedex with the terms: thiamine, diabetes, retinopathy, neuropathy and nephropathy between the years 1988 till 2015. Among 50 related articles, 38 with the full text access were included.

Results: Thiamine blocks many harmful hyperglycemia-pathway like: hexosamine pathway, AGE formation, PKC activation; though it increases the activation of transketolase enzyme. Thus thiamine is a good therapeutic option.

Keywords: thiamine, diabetes, nephropathy, retinopathy, neuropathy
Full-Text [PDF 453 kb]   (8419 Downloads)    
Type of Study: Review | Subject: بیوشیمی
Received: 2016/06/29 | Accepted: 2016/06/29 | Published: 2016/06/29


XML   Persian Abstract   Print



Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
year 8, Issue 31 (6-2016) Back to browse issues page